The 6.89x trailing EV/EBITDA and 3.75x forward figure both sit well below EXP's 9.45x and far beneath the 16x range of MLM and VMC, despite CX's 2026Q3 ROIC of 8.5% actually exceeding MLM's 7.6%. This gap appears wider than a conventional EM discount would justify and may reflect skepticism about the durability of the 2026 rebound, particularly given two consecutive quarters of withheld forward guidance per CX's earnings disclosures. The 8.4% dividend yield versus sub-1% for all three US peers suggests the equity is being priced for capital-loss protection rather than growth, which could represent either a genuine value opportunity or a signal that the market expects the payout to be reassessed.

The 35.5% gross margin in 2026Q3 should be read alongside CX's structurally low asset turnover of 0.16x — in a business where revenue is largely a function of volume and price, gross margin is effectively the primary profitability lever CX can control. The 38.9% operating margin breaks sharply from the 6.8-14.8% band in the prior nine quarters and, absent a disclosed one-off, may reflect either an unusual favorable item or a genuine step-change in fixed-cost absorption that would argue for a higher structural multiple. Net margin of 8.9% still sits roughly half of EXP's 18.4% and MLM's 17.4%, indicating CX retains a structural cost disadvantage relative to US-focused peers despite the recent recovery.

Asset turnover has been essentially flat at 0.13-0.16x across all ten reported quarters, so the entire ROIC improvement appears attributable to margin expansion rather than capital efficiency — a distinction that matters because margin-driven returns are more reversible than efficiency-driven ones. The 8.5% print in 2026Q3, if sustained, would place CX's capital productivity roughly in line with VMC (8.8%) and above MLM (7.6%), which is notable given CX's larger emerging-market asset base and higher implied cost of capital. However, EXP's 14.8% ROIC highlights how much further CX would need to travel to reach peer-leading returns, and the declining net PP&E noted in CX's quarterly balance sheet filings raises the question of whether maintenance-level capital expenditure can sustain these returns.

The D/E oscillation between 0.22 and 0.62 without a clear directional trend, combined with Debt/EBITDA ranging from 4.73 to 16.49 across the same window, suggests both ratios are more sensitive to quarterly EBITDA volatility than to actual changes in the debt stack. Interest coverage's recovery to 5.56 from the negative print in 2025Q4 appears meaningful on its face, but the swing is largely mechanical given the depressed earnings base in that quarter rather than a demonstrable step-change in debt reduction. Compared to EXP at 1.22 D/E, CX's reported leverage appears moderate, yet the missing D/E and D/EBITDA figures in 2026Q3 prevent any confident conclusion about whether the investment-grade-driven deleveraging narrative is actually playing out.

The persistent sub-unity current ratio alongside quick ratios of 0.58-0.73 indicates roughly 30% of current assets are tied up in inventory — which for cement is largely finished goods awaiting delivery — a modest risk given the stable 47-56 day DIO window. The strategic interpretation is that CX appears to be running negative working capital by design, collecting receivables in 53-61 days while taking 89-109 days to pay suppliers, which effectively funds operations with supplier credit. This is a recognizable pattern among capital-intensive industrial businesses with strong bargaining power, but it does leave CX more exposed than MLM or VMC to a scenario where suppliers tighten terms during a credit contraction, particularly in markets where CX lacks dominant local share.